Sequent Asset Management’s AstraZeneca AZN Stock Holding History

Sequent Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,423	Closed	-$222K	–	89
2024 Q3	$222K	Hold	1,423	–	–	0.11%	84
2024 Q2	$222K	Sell	1,423 -701	-33%	-$105K	0.11%	87
2024 Q1	$288K	Hold	2,124	–	–	0.15%	64
2023 Q4	$286K	Hold	2,124	–	–	0.17%	64
2023 Q3	$288K	Hold	2,124	–	–	0.32%	44
2023 Q2	$304K	Hold	2,124	–	–	0.33%	44
2023 Q1	$295K	Hold	2,124	–	–	0.33%	49
2022 Q4	$288K	Hold	2,124	–	–	0.19%	56
2022 Q3	$233K	Hold	2,124	–	–	0.17%	62
2022 Q2	$281K	Hold	2,124	–	–	0.21%	59
2022 Q1	$282K	Hold	2,124	–	–	0.17%	64
2021 Q4	$247K	Hold	2,124	–	–	0.13%	66
2021 Q3	$255K	Buy	+2,124	New	+$247K	0.15%	61

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Sequent Asset Management's AZN Position: Q4 2024 in Review

Sequent Asset Management sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 1,423 shares — an estimated $222K sold.

Sequent Asset Management first reported a position in AZN in Q3 2021 and held it in 13 quarters. The position peaked at $304K in Q2 2023. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

Sequent Asset Management reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
Sequent Asset Management sold 1,423 AstraZeneca shares in Q4 2024, an estimated $222K.
Sequent Asset Management first reported a position in AstraZeneca in Q3 2021 and held it in 13 quarters.
Sequent Asset Management's AstraZeneca position peaked at $304K in Q2 2023.
1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Sequent Asset Management's 13F filing for Q4 2024, filed 24 Jan 2025.